Janus Henderson Group’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.49M Buy
316,519
+28,958
+10% +$548K ﹤0.01% 929
2025
Q4
$5.42M Buy
287,561
+265,661
+1,213% +$4.45M ﹤0.01% 906
2025
Q3
$318K Hold
21,900
﹤0.01% 2188
2025
Q2
$428K Hold
21,900
﹤0.01% 2020
2025
Q1
$394K Hold
21,900
﹤0.01% 2082
2024
Q4
$468K Hold
21,900
﹤0.01% 2065
2024
Q3
$684K Buy
+21,900
New +$545K ﹤0.01% 1875
2023
Q4
Sell
-23,653
Closed -$165K 2563
2023
Q3
$165K Buy
23,653
+5
+0% +$46 ﹤0.01% 2426
2023
Q2
$201K Sell
23,648
-32
-0.1% -$267 ﹤0.01% 2442
2023
Q1
$217K Buy
23,680
+13,149
+125% +$168K ﹤0.01% 2452
2022
Q4
$120K Hold
10,531
﹤0.01% 2304
2022
Q3
$180K Buy
10,531
+19
+0.2% +$408 ﹤0.01% 1906
2022
Q2
$226K Sell
10,512
-13
-0.1% -$361 ﹤0.01% 2241
2022
Q1
$389K Buy
10,525
+2
+0% +$78 ﹤0.01% 2053
2021
Q4
$479K Buy
10,523
+5,294
+101% +$276K ﹤0.01% 1914
2021
Q3
$331K Buy
+5,229
New +$398K ﹤0.01% 1837

Other funds holding CDNA

Janus Henderson Group's CDNA Position: Q1 2026 in Review

Janus Henderson Group increased its CareDx (CDNA) stake by 10% in Q1 2026, buying an estimated $548K and bringing the position to 316,519 shares worth $5.49M. The position accounts for ﹤0.01% of the portfolio, ranked #929.

Janus Henderson Group first reported a position in CDNA in Q3 2021 and has held it in 16 quarters since. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Janus Henderson Group held 316,519 shares of CareDx worth $5.49M as of Q1 2026.
  • Janus Henderson Group bought 28,958 CareDx shares in Q1 2026, an estimated $548K.
  • CareDx made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #929 holding.
  • Janus Henderson Group first reported a position in CareDx in Q3 2021 and has held it in 16 quarters since.
  • 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.